Description
Octalmol Pharmacodynamics
Aminobenzoic acid is an interferon inducer, has antioxidant, immunomodulatory, radioprotective effect, accelerates corneal regeneration.
The drug does not have teratogenic, mutagenic, embryotoxic effects.
Indications
As monotherapy and as part of the complex therapy of viral eye lesions:
– Conjunctivitis, keratoconjunctivitis, keratouveitis caused by herpes virus (herpes simplex, herpes zoster), adenoviruses;
– Keratopathies of infectious, post-traumatic and postoperative genesis.
Contraindications
Individual hypersensitivity to the components of the drug.
Application during pregnancy and lactation
Up to now, the data of clinical trials concerning Octalmol® usage during pregnancy, lactation and in children are absent.
However the drug can be used in case if the assumed benefit exceeds the risk.
Dosage and administration method
- The drug is instilled into the conjunctival sac in 1-2 drops 6-8 times a day.
- After clinical recovery, continue instillation 2 drops 3 times daily for 7 days
